1. Home
  2. GLBS vs CASI Comparison

GLBS vs CASI Comparison

Compare GLBS & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLBS
  • CASI
  • Stock Information
  • Founded
  • GLBS 2006
  • CASI 1991
  • Country
  • GLBS Greece
  • CASI China
  • Employees
  • GLBS N/A
  • CASI N/A
  • Industry
  • GLBS Marine Transportation
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • GLBS Consumer Discretionary
  • CASI Health Care
  • Exchange
  • GLBS Nasdaq
  • CASI Nasdaq
  • Market Cap
  • GLBS 23.7M
  • CASI 20.5M
  • IPO Year
  • GLBS 2007
  • CASI 1996
  • Fundamental
  • Price
  • GLBS $1.16
  • CASI $1.20
  • Analyst Decision
  • GLBS Strong Buy
  • CASI Strong Buy
  • Analyst Count
  • GLBS 1
  • CASI 1
  • Target Price
  • GLBS $3.00
  • CASI $4.00
  • AVG Volume (30 Days)
  • GLBS 75.2K
  • CASI 298.4K
  • Earning Date
  • GLBS 06-16-2025
  • CASI 08-15-2025
  • Dividend Yield
  • GLBS N/A
  • CASI N/A
  • EPS Growth
  • GLBS N/A
  • CASI N/A
  • EPS
  • GLBS N/A
  • CASI N/A
  • Revenue
  • GLBS $35,776,000.00
  • CASI $31,368,000.00
  • Revenue This Year
  • GLBS $33.39
  • CASI N/A
  • Revenue Next Year
  • GLBS $22.81
  • CASI N/A
  • P/E Ratio
  • GLBS N/A
  • CASI N/A
  • Revenue Growth
  • GLBS 17.92
  • CASI 8.39
  • 52 Week Low
  • GLBS $0.99
  • CASI $1.10
  • 52 Week High
  • GLBS $2.21
  • CASI $7.67
  • Technical
  • Relative Strength Index (RSI)
  • GLBS 48.76
  • CASI 29.29
  • Support Level
  • GLBS $1.15
  • CASI $1.22
  • Resistance Level
  • GLBS $1.40
  • CASI $1.42
  • Average True Range (ATR)
  • GLBS 0.11
  • CASI 0.28
  • MACD
  • GLBS -0.01
  • CASI -0.04
  • Stochastic Oscillator
  • GLBS 11.11
  • CASI 5.49

About GLBS Globus Maritime Limited

Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: